November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Study Finds Unchecked Additives in Majority of Compounded Weight-Loss Drugs

🧠 AI Analysis 2 min read 👁 4

Recent research published in JAMA reveals that compounded GLP-1 medications, which now comprise a large portion of weight-loss prescriptions, frequently feature untested additives like vitamin B12 analogs.

Study Finds Unchecked Additives in Majority of Compounded Weight-Loss Drugs🧠AI Analysis

Photo: Medical Xpress

Key points

  • Compounded GLP-1 medications accounted for 86% of compounded weight-loss prescriptions by 2025 in the Nebraska dataset.
  • Commonly added substances include vitamin B12 analogs and levocarnitine without established safety data.
  • Cash-pay purchases make these products largely invisible to traditional insurance claims tracking.

A recent investigation published in the journal JAMA highlights that the vast majority of compounded weight-loss medications now consist of GLP-1 receptor agonists mixed with additional active ingredients. Led by researchers from the University of Utah Health Sciences, the study examined dispensing patterns using a comprehensive prescription tracking database from Nebraska, noting that these compounded formulations surged from nonexistence in 2018 to account for 86 percent of all compounded weight-loss prescriptions by 2025.

Many of these alternative formulations incorporate substances such as cyanocobalamin, a vitamin B12 analog, and levocarnitine. Vendors often market these additives as a way to mitigate common side effects associated with GLP-1 treatments. However, the study points out that these specific combinations lack formal safety testing, and evidence supporting their efficacy remains scarce.

Because the cash-pay nature of these products generally bypasses standard insurance claims databases, tracking their distribution has proven difficult. Lead author Joey Mattingly notes that compounded alternatives differ significantly from FDA-approved medications, leaving the overall quality, composition, and potential risks largely unverified for patients who inject them.

What to know: Patients and physicians should carefully verify the origin of weight-loss medications, as compounded GLP-1s often contain unmonitored additives. Always consult a qualified healthcare provider regarding personal treatment decisions and medication safety.

Source Medical Xpress — medicalxpress.com/news/2026-11-glp-1s-untested-additive-combinations.ht… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.